granisetron has been researched along with Hematologic Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, Z; Guan, F; Guo, QS; Liu, ZF; Wang, MY; Yang, XG; Zhang, XQ | 1 |
| Goram, AL; Richmond, PL | 1 |
1 trial(s) available for granisetron and Hematologic Diseases
| Article | Year |
|---|---|
Biweekly oxaliplatin in combination with continuous infusional 5-fluorouracil and leucovorin (modified FOLFOX-4 regimen) as first-line chemotherapy for elderly patients with advanced gastric cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Hypersensitivity; Female; Fluorouracil; Follow-Up Studies; Granisetron; Hematologic Diseases; Humans; Infusions, Intravenous; Leucovorin; Male; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Premedication; Stomach Neoplasms; Survival Rate; Treatment Outcome | 2008 |
1 other study(ies) available for granisetron and Hematologic Diseases
| Article | Year |
|---|---|
Pegylated liposomal doxorubicin: tolerability and toxicity.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Diphenhydramine; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Female; Granisetron; Hematologic Diseases; Humans; Liposomes; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Ovarian Neoplasms; Paresthesia; Premedication; Prochlorperazine; Ranitidine; Stomatitis; Tamoxifen; Treatment Failure | 2001 |